Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages

Clinical and Experimental Allergy

Volumn 25, Issue 7, 1995, Pages 625-633

  Tenor, H ^a   Hatzelmann, A ^a   Kupferschmidt, R ^a   Stanciu, L ^a   Djukanovic, R ^a   Schudt, C ^a   Wendel, A ^a   Church, M K ^a   Shute, J K ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alveolar macrophages; Isoenzyme; Maturation; Monocytes; Phosphodiesterase

Indexed keywords

CALMODULIN; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ISOENZYME; MOTAPIZONE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SNAKE VENOM; ZAPRINAST; ZARDAVERINE;

ALLERGIC ASTHMA; CELL MATURATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MONOCYTE; PRIORITY JOURNAL;

EID: 0029129372     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1995.tb01110.x     Document Type: Conference Paper

References (37)

1. 1 Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defence and injury. Am Rev Resp Dis 1990 ; 141: 471–501.
2. 2 Lee TH, Lane SJ. The role of macrophages in the mechanism of airway inflammation in asthma. Am Rev Resp Dis 1992 ; 145: S27–S30.
3. 3 Chanez P. Vago P, Demoly P et al. Airway macrophages from patients with asthma do not proliferate. J Allergy Clin Immunol 1993 ; 92: 869–77.
4. 4 Lyons CR. Ball EJ, Taews GB et al. Inability of human alveolar macrophages to stimulate resting T‐cells correlates with decreased antigen‐specific T‐cell‐macrophage binding. J Immunol 1986 ; 137: 1173–80.
5. 5 Wewers MD, Herzyk DJ. Alveolar macrophages differ from blood monocyles in human IL‐1β release. J Immunol 1989 ; 143: 1635–41.
6. 6 Galve de Rochemonteix B, Nicod LP, Chicheportiche R et al. Regulation of interleukin‐Ira. interleukin‐la. and interleukin‐1β production by human alveolar macrophages with phorbol myristale acetate, lipopolysaccharide and interleukin‐4, Am J Resp Cell Mol Biol 1993 ; 8: 160–8.
7. 7 Hart PH, Ahern MJ, Jones KL, Smith MD. Finlay‐Jones JJ. Synovial fluid macrophages and blood monocytes differ in their response to IL‐4. J Immunol 1993 ; 151: 3370–80.
8. 8 Van Hal PTW. Hopstaken‐Broos JPM, Wijkhuijs JM et al. Regulation of aminopeptidase N (CD13) and Fce RIIb (CD23) expression by IL‐4 depends on the stage of maturation of monocytes/macrophages. J Immunol 1992 ; 149: 1395–401.
9. 9 Gessani S. Tesla U, Varano B et al. Enhanced production of LPS‐induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors. J Immunol 1993: 151: 3758–66.
10. 10 Poston R. Chanez P, Lacoste JY et al. Immunohistochemical characterizalion of the cellular infiltration of asthmatic bronchi, Am Rev Rep Dis 1992: 145: 918–21.
11. 11 Chanez P. Bousquet J, Couret I et al. Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. Am Rev Respir Dis 1991 ; 144: 923–30.
12. 12 Laitinen LA. Laitinen A, Haahteka T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Resp Dis 1993 ; 147: 697–704.
13. 13 Runkin JA. The contribution of alveolar macrophages to hyperreactive airway disease. J Allergy Clin Immunol 1989 ; 83: 722–9.
14. 14 Carrol MP. Holgate ST. Monocytes and asthma. In: Zembala M, Asherson GL. eds. Human monocytes London: Academic Press. 1989: 493–501.
15. 15 Fish JE, Yoss EB, Peters SP. Bronchoalveolar lavage in asthma: cellular and mediator composition and macro‐phage function studies. In: Mygind N, Pipkorn U. Dahl R, eds. Rhinitis and asthma: similarities and differences Copenhagen: Munksgaard, 1990: 222–32.
16. 16 Schudt C, Tenor H, Loos U, Mallmann P, Szamel M, Resch K. Effects of selective PDE inhibitors on activation of human macrophages and lymphocytes, Eur Resp J 1993 ; 6 (Suppl 17): 367S.
17. 17 Fuller RW. O'Malley G, Baker AJ. MacDermot J. Human alveolar macrophage activation: inhibition by forskolin but not β‐adrenoceptor stimulation or phsophodiesterase inhibition. Pul Pharmacol 1988: 1: 101–6.
18. 18 Beavo JA. Reifsnyder DH. Primary sequence of cyclic nucteotide phosphodiesterase isoenzymes and the design of selective inhibitors. TIPS 1990 ; 11: 150–5.
19. 19 Giembycz MA, Dent G. Prospects for selective cyclic nucleolide phosphodieslerase inhibitors in the treatment of bronchial asthma. Clin Exp Allergy 1992 ; 22: 337–44.
20. 20 Bachelet M. Vincent D, Havet N et al. Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma. J Allergy Clin Immunol 1991 ; 88: 322–8.
21. 21 Thompson WJ, Appleman MM. Assay of cyclic nucleotide phosphodieslerase and resolution of multiple molecular forms of the enzyme. Adv Cycl Nucl Res 1979 ; 10: 69–92.
22. 22 Bauer AC. Schwabe U. An improved assay of cyclic 3′,5′‐nucleotidephosphodiesterase with QAE Sephadex A‐25. Naunyn-Schmiedebergs Arch Pharmacol 1980: 311: 193–8.
23. 23 Tenor H, Stanciu L, Schudt C et al. Cyclic nucleo‐tide phosphodiesterases from purified human CD4 and CD8 T‐lymphocytes. Clin Exp Allergy. 1995 ; 25: 616–24.
24. 24 Rabe KF. Tenor H. Dent G et al. Identification of phosphodiesterase‐isoenzymes in human pulmonary artery and the effects of selective PDE‐inhibitors. Am J Physiol 1994 ; In press.
25. 25 Rabe KF, Tenor H, Dent G et al. Phosphodiesterase isoenzymes modulating inherent lone in human airways: identification and characterization. Am J Physiol 1993 ; 264: L458–L464.
26. 26 Dent G, Giembycz MA. Wolf B et al. Identification of PDE III and PDE IV isoenzymes of cAMP PDE in human alveolar macrophages. Am Rev Resp Dis 1993 ; 147: A184.
27. 27 Elliot KFR, Leonhard EJ. Interactions of formylmethionyl‐leucyl‐phenylalanine, adenosine. and phosphodiesterase inhibitors in human monocyles. Effects on superoxide release, inositol phosphates and cAMP. FEBS Letts 1989 ; 254: 94–8.
28. 28 Grewe SR. Chan SC. Hanifin JM. Elevated leukocyte cyclic AMP phosphodieslerase in alopic disease: a possible mechanism for cAMP‐agonist hyporesponsiveness. J Allergy Clin Immunol 1982 ; 70: 452–7.
29. 29 Chan SC, Reifsnyder D, Beavo JA. Hanifin JM. Immuno‐chemical characterization of the distinct monocyte cyclic AMP phosphodiesterase from patients with atopic dermatitis. J Allergy Clin Immunol 1993: 91: 1179–88.
30. 30 Te Velde AA, Klomp JPG, Yard BA, de Vries JE, Figdor CG. Modulation of phenolypic and functional properties of human peripheral blood monocytes by IL4. J Immunol 1988 ; 140: 1548–54.
31. 31 Li SH, Chan SC, Toshitani A, Leung DYM, Hanifin JM. Synergistic effects of interleukin‐4 and interferon gamma on monocyte phosphodiesterase activity. J Invest Dermatol 1992: 99: 65–70.
32. 32 Hashimolo S, Amemiya E. Tomita Y et al. Elevation of soluble IL2 receptor and IL4. and nonelevalion of IFN‐γ in sera from patients with allergic asthma. Ann Allergy 1993 ; 71: 455–8.
33. 33 Torphy TJ. Zhou HL, Cieslinski LB. Slimulalion of beta adrenoceplors in a human monocyte cell line (U937) up‐regulates cyclic AMP‐specific phosphodieslerase aclivity. J Pharmacol Exp Ther 1992 ; 263: 1195–205.
34. 34 Tenor H, Wendel A. Schudt C. Regulation of PDE IV isoenzyme activity in HaCaT cells by cAMP increasing agents. Naunyn-Schmiedebergs Arch Pharmacol 1993 ; 347S: R112.
35. 35 Molnar‐Kimber K. Yonno L, Heaslip R. Weichman B. Modulation of TNF α and IL‐1β from endotoxin‐stimulated monocyles by selective PDE isoenzyme inhibitors, Agenis Actions 1993: 39: C77–C79.
36. 36 Murray KJ, England PJ. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents. Biochem Soc Trans 1992 ; 20: 460–4.
37. 37 Bachelet M, Chouaid C, Havel N et al. Modulation of arachidonic acid metabolism and cAMP content of human alveolar macrophages. Eicosanoids in press.